The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.

Published in:

2010

By:

• Kox, C.;
• Zimmermann, M.;
• Stanulla, M.;
• Leible, S.;
• Schrappe, M.;
• Ludwig, W.-D.;
• Koehler, R.;
• Tolle, G.;
• Bandapalli, O. R.;
• Breit, S.;
• Muckenthaler, M. U.;
• Kulozik, A. E.

Publication type:

journal article